The Evolution of College Entrance Examinations

Over the last 150 years, one of the hallmarks of American education has been the testing of increasingly large groups of people through processes of growing sophistication made possible by continuing advances in the technology of information processing. Much of this testing has been largely external to the instructional process, driven by the interests of policymakers and governments, especially vis-à-vis grades K-12, and has served various ends

Soil Compaction Research Summary

Soil compaction has become a major topic of discussion among scientists and crop producers in recent years. Even though some producers consider soil compaction to be a problem on their own farms, they feel resigned to the fact that there is little they can do to control it. Some recent solutions have been offered based on research efforts with soil compaction. There is significant interest in developing crop production systems with controlled traffic to help control the problem of soil compaction. There have also been new machine developments to address the problem of soil compaction, particularly with rubber tracked equipment and lower pressure tires

Use of Most Bothersome Symptom as a Coprimary Endpoint in Migraine Clinical Trials: A Post-Hoc Analysis of the Pivotal ZOTRIP Randomized, Controlled Trial.

ObjectiveTo better understand the utility of using pain freedom and most bothersome headache-associated symptom (MBS) freedom as co-primary endpoints in clinical trials of acute migraine interventions.BackgroundAdhesive dermally applied microarray (ADAM) is an investigational system for intracutaneous drug administration. The recently completed pivotal Phase 2b/3 study (ZOTRIP), evaluating ADAM zolmitriptan for the treatment of acute moderate to severe migraine, was one of the first large studies to incorporate MBS freedom and pain freedom as co-primary endpoints per recently issued guidance by the US Food and Drug Administration. In this trial, the proportion of patients treated with ADAM zolmitriptan 3.8 mg, who were pain-free and MBS-free at 2 hours post-dose, was significantly higher than for placebo.MethodsWe undertook a post-hoc analysis of data from the ZOTRIP trial to examine how the outcomes from this trial compare to what might have been achieved using the conventional co-primary endpoints of pain relief, nausea, photophobia, and phonophobia.ResultsOf the 159 patients treated with ADAM zolmitriptan 3.8 mg or placebo, prospectively designated MBS were photophobia (n = 79), phonophobia (n = 43), and nausea (n = 37). Two-hour pain free rates in those with photophobia as the MBS were 36% for ADAM zolmitriptan 3.8 mg and 14% for placebo (P = .02). Corresponding rates for those with phonophobia as the MBS were 14% and 41% (P = .05). For those whose MBS was nausea, corresponding values were 56% and 16%, respectively (P = .01). Two-hour freedom from the MBS for active drug vs placebo were 67% vs 35% (P < .01) for photophobia, 55% vs 43% (P = .45) for phonophobia, and 89% vs 58% for nausea (P = .04). MBS freedom but not pain freedom was achieved in 28%. Only 1 patient (1%) achieved pain freedom, but not MBS freedom. The proportion with both pain and MBS freedom was highest (56%) among those whose MBS was nausea.ConclusionIn this study, the use of MBS was feasible and seemed to compare favorably to the previously required 4 co-primary endpoints

Improvement of Lipid Absorption in Young Pigs as a Model for Preterm Infants

Preterm infants and neonatal suckling piglets have a limited bile acid pool that may hinder absorption of dietary lipids such as fatty acids, triacylglycerols (TAGs), and other lipid-soluble nutrients. Because dietary lipids are a valuable source of energy for growth, it is important that they are efficiently absorbed. The hypothesis of this study is that oral administration of 0.2 g/kg body weight daily of cholylsarcosine, an artificial bile acid, would decrease fecal excretion of dietary fatty acids and TAGs in suckling piglets. Twelve 7-d-old piglets were housed individually and fed a commercial milk replacer with or without oral cholylsarcosine until 21 d of age. Cholylsarcosine treatment decreased fecal excretion of stearic acid (18:0) and palmitic acid (16:0) (P ≤ 0.02). Cholylsarcosine supplementation had no effect on absorption of unsaturated fatty acids of 16 or 18 carbons (P \u3e 0.05). Cholylsarcosine increased fecal excretion of deoxycholic acid (P = 0.03). Apparent absorption of dietary TAGs was increased from 77% in piglets not fed cholylsarcosine to 83% in the piglets that received oral cholylsarcosine. These results support the hypothesis that cholylsarcosine increases absorption of dietary TAGs

U.S. GLOBAL CHANGE RESEARCH PROGRAM CLIMATE SCIENCE SPECIAL REPORT (CSSR)

Fifth-Order Draft Table of Contents Front Matter About This Report........................................................................................ 1 Guide to the Report......................................................................................4 Executive Summary ................................................................................... 12 Chapters 1. Our Globally Changing Climate .......................................................... 38 2. Physical Drivers of Climate Change ................................................... 98 3. Detection and Attribution of Climate Change .................................... 160 4. Climate Models, Scenarios, and Projections .................................... 186 5. Large-Scale Circulation and Climate Variability ................................ 228 6. Temperature Changes in the United States ...................................... 267 7. Precipitation Change in the United States ......................................... 301 8. Droughts, Floods, and Hydrology ......................................................... 336 9. Extreme Storms ....................................................................................... 375 10. Changes in Land Cover and Terrestrial Biogeochemistry ............ 405 11. Arctic Changes and their Effects on Alaska and the Rest of the United States..... 443 12. Sea Level Rise ....................................................................................... 493 13. Ocean Acidification and Other Ocean Changes .............................. 540 14. Perspectives on Climate Change Mitigation .................................... 584 15. Potential Surprises: Compound Extremes and Tipping Elements .......... 608 Appendices A. Observational Datasets Used in Climate Studies ............................. 636 B. Weighting Strategy for the Fourth National Climate Assessment ................ 642 C. Detection and Attribution Methodologies Overview ............................ 652 D. Acronyms and Units ................................................................................. 664 E. Glossary ...................................................................................................... 66

U.S. GLOBAL CHANGE RESEARCH PROGRAM CLIMATE SCIENCE SPECIAL REPORT (CSSR)

Fifth-Order Draft Table of Contents Front Matter About This Report........................................................................................ 1 Guide to the Report......................................................................................4 Executive Summary ................................................................................... 12 Chapters 1. Our Globally Changing Climate .......................................................... 38 2. Physical Drivers of Climate Change ................................................... 98 3. Detection and Attribution of Climate Change .................................... 160 4. Climate Models, Scenarios, and Projections .................................... 186 5. Large-Scale Circulation and Climate Variability ................................ 228 6. Temperature Changes in the United States ...................................... 267 7. Precipitation Change in the United States ......................................... 301 8. Droughts, Floods, and Hydrology ......................................................... 336 9. Extreme Storms ....................................................................................... 375 10. Changes in Land Cover and Terrestrial Biogeochemistry ............ 405 11. Arctic Changes and their Effects on Alaska and the Rest of the United States..... 443 12. Sea Level Rise ....................................................................................... 493 13. Ocean Acidification and Other Ocean Changes .............................. 540 14. Perspectives on Climate Change Mitigation .................................... 584 15. Potential Surprises: Compound Extremes and Tipping Elements .......... 608 Appendices A. Observational Datasets Used in Climate Studies ............................. 636 B. Weighting Strategy for the Fourth National Climate Assessment ................ 642 C. Detection and Attribution Methodologies Overview ............................ 652 D. Acronyms and Units ................................................................................. 664 E. Glossary ...................................................................................................... 66

A Re-Examination of the Taxonomic Boundaries of \u3cem\u3eSymphysia\u3c/em\u3e (Ericaceae)

DNA sequence data were generated for the nuclear ITS region for Symphysia racemosa and for 26 additional Vaccinieae representing 12 sections in the genus Vaccinium plus one species from each of five additional segregate genera. Our focus is on the placement of S. racemosa relative to Vaccinium sensu scricto and Vaccinium sect. Oreades (represented by V. poasanum). Maximum parsimony analysis of 608 bp of nrITS region suggests that S. racemosa and V. poasanum form a well-supported clade in spite of substantial morphological divergence. Futhermore, this clade is a sister group to a clade consisting of all segregate genera examined. These molecular results led us to undertake a morphological cladistic analysis of all of the other Central American green-flowered taxa. We suggest that the genus Symphysia should be expanded to encompass these 15 taxa, despite the lack of phylogenetic resolution within this group. This will necessitate eight new combinations, via. Symphysia almedae (= V. almedae), Symphysia costaricensis (= V. costaricense), Symphysia jefensis (= V. jefense), Symphysia orosiensis (= V. orosiense), Symphysia ovata (= Lateropora ovata), Symphysia perardua (= V. santafeënsis), Symphysia poasana (= Vaccinium poasanum), Symphysia santafeënsis (= L. santafeënsis), and Symphysia tubulifera (= L. tubulifera)

Mitigation and screening for environmental assessment

This article considers how, as a matter of law and policy, mitigation measures should be taken into account in determining whether a project will have significant environmental effects and therefore be subject to assessment under the EU Environmental Impact Assessment (EIA) Directive. This is not straightforward: it is problematic to distinguish clearly between an activity and the measures proposed to minimise or mitigate for the adverse consequences of the activity. The issue is a salient one in impact assessment law, but under-explored in the literature and handled with some difficulty by the courts. I argue that there is an unnecessarily and undesirably narrow approach currently taken under the EIA Directive, which could be improved upon by taking a more adaptive approach; alternatively a heightened standard of review of ‘significance’, and within this of the scope for mitigation measures to bring projects beneath the significance threshold, may also be desirable

Spina bifida: A multidisciplinary perspective on a many-faceted condition

Open spina bifida or myelomeningocele (SBM) is the most common birth defect involving the central nervous system, second only in incidence to congenital cardiac disease. Outcomes in this disorder were poor until the mid-20th century, when modern neurosurgical techniques (closing the lesion and treating hydrocephalus) and treatment for the neuropathic bladder addressed the major causes of mortality, although SBM may still be poorly treated in the developing world. Initial management – or mismanagement – has a profound impact on survival and long-term quality of life